Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Preterm infants Paracetamol Study

Trial Profile

The Preterm infants Paracetamol Study

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Paracetamol (Primary)
  • Indications Pain; Patent ductus arteriosus
  • Focus Therapeutic Use
  • Acronyms PreParaS
  • Most Recent Events

    • 02 Apr 2019 Status changed from completed to recruiting.
    • 20 May 2016 Primary endpoint has been met. (Decrease in and closure of the ductus during the intervention as function of postnatal age), as per results published in the Journal of Pediatrics.
    • 20 May 2016 Results published in the Journal of Pediatrics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top